Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients

NCT ID: NCT06108973

Last Updated: 2023-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2025-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic Obstructive pulmonary disease is known to escalate the consumption of Inhalation Agents in General Anesthesia. Hence the Data to Collect the Official Record

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal Patients

Normal patients without any Lung Pathology for General Anesthesia

Capnography

Intervention Type DEVICE

To know the Co2 graph in COPD and Normal patients under General Anesthesia

COPD patients

Established Chronic Obstructive Pulmonary Disease for General Anesthesia

Capnography

Intervention Type DEVICE

To know the Co2 graph in COPD and Normal patients under General Anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Capnography

To know the Co2 graph in COPD and Normal patients under General Anesthesia

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both Sex All Age Group Patient willing to give consent COPD patient

Exclusion Criteria

* Not willing to give consent Cancerous Lung Lung Lobectomy
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Spine LLC

INDUSTRY

Sponsor Role collaborator

Employee's State Insurance Corporation, New Delhi

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Santhosh Kumar T N

Nursing Orderly

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr Manjunath, MD

Role: PRINCIPAL_INVESTIGATOR

ESIC

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Santhosh Kumar T N, BSc

Role: CONTACT

6366470104

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00127102023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimization of Desflurane in Elderly Patients
NCT01700907 COMPLETED PHASE1/PHASE2